DLABORATORY SWEDEN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 SEK | +3.41% |
|
-6.61% | +7.61% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 70.91 | 56.77 | 33.38 |
| Enterprise Value (EV) 1 | 44.32 | 42.98 | 23.29 |
| P/E ratio | -4.4 x | -6.32 x | -3.02 x |
| Yield | - | - | - |
| Capitalization / Revenue | 3.93 x | 1.24 x | 0.74 x |
| EV / Revenue | 2.46 x | 0.94 x | 0.52 x |
| EV / EBITDA | -3.11 x | -5.33 x | -2.75 x |
| EV / FCF | -6,636,030 x | -3,998,853 x | 118,910,540 x |
| FCF Yield | -0% | -0% | 0% |
| Price to Book | 1.92 x | 2.01 x | 1.92 x |
| Nbr of stocks (in thousands) | 16,945 | 16,945 | 16,945 |
| Reference price 2 | 4.185 | 3.350 | 1.970 |
| Announcement Date | 08/04/22 | 14/04/23 | 09/04/24 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.331 | 7.351 | 4.754 | 18.05 | 45.76 | 44.9 |
| EBITDA 1 | -6.605 | -7.548 | -13.45 | -14.23 | -8.06 | -8.469 |
| EBIT 1 | -7.026 | -8.065 | -13.47 | -15.33 | -10.64 | -11.05 |
| Operating Margin | -162.24% | -109.71% | -283.23% | -84.91% | -23.24% | -24.6% |
| Earnings before Tax (EBT) 1 | -7.114 | -8.159 | -13.62 | -15.44 | -9.116 | -11.05 |
| Net income 1 | -7.114 | -8.159 | -13.62 | -16.13 | -8.987 | -11.05 |
| Net margin | -164.27% | -110.99% | -286.4% | -89.35% | -19.64% | -24.61% |
| EPS | - | -22.78 | -26.22 | -0.9518 | -0.5304 | -0.6522 |
| Free Cash Flow | - | - | -4.665 | -6.678 | -10.75 | 0.1959 |
| FCF margin | - | - | -98.11% | -37% | -23.48% | 0.44% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 06/05/20 | 06/05/20 | 22/02/21 | 08/04/22 | 14/04/23 | 09/04/24 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.58 | - | - | - | - | - |
| Net Cash position 1 | - | 0.35 | 4.65 | 26.6 | 13.8 | 10.1 |
| Leverage (Debt/EBITDA) | -0.0875 x | - | - | - | - | - |
| Free Cash Flow | - | - | -4.66 | -6.68 | -10.7 | 0.2 |
| ROE (net income / shareholders' equity) | -140% | -222% | -226% | -74.8% | -27.6% | -48.5% |
| ROA (Net income/ Total Assets) | -52.6% | -62.8% | -77.7% | -32.5% | -15.4% | -20.1% |
| Assets 1 | 13.52 | 12.99 | 17.51 | 49.61 | 58.24 | 54.9 |
| Book Value Per Share | - | 16.20 | 12.10 | 2.180 | 1.670 | 1.020 |
| Cash Flow per Share | - | 9.120 | 13.90 | 1.660 | 0.8700 | 0.6200 |
| Capex | - | - | - | 0.19 | - | - |
| Capex / Sales | - | - | - | 1.02% | - | - |
| Announcement Date | 06/05/20 | 06/05/20 | 22/02/21 | 08/04/22 | 14/04/23 | 09/04/24 |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +7.61% | 3.24M | |
| -12.65% | 193B | |
| +2.64% | 167B | |
| +5.51% | 160B | |
| +8.65% | 104B | |
| +36.73% | 83.55B | |
| +12.22% | 82.75B | |
| -4.57% | 72.35B | |
| -19.69% | 54.73B | |
| -7.68% | 43.68B |
- Stock Market
- Equities
- DLAB Stock
- Financials Dlaboratory Sweden AB
